Expression and DNA-binding activity of signal transducer and activator of transcription 3 in alcoholic cirrhosis compared to normal liver and primary biliary cirrhosis in humans

American Journal of Pathology

Volumn 162, Issue 2, 2003, Pages 587-596

  Stärkel, Peter ^a   Bishop, Kate ^b   Horsmans, Yves ^a   Straint, Alastair J ^b  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^b UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; DNA BINDING PROTEIN; INTERLEUKIN 6; MESSENGER RNA; SERINE; STAT PROTEIN; STAT3 PROTEIN; SUPPRESSOR FACTOR; SUPPRESSOR OF CYTOKINE SIGNALING; SUPPRESSOR OF CYTOKINE SIGNALING 3; TYROSINE; UNCLASSIFIED DRUG;

ALCOHOL LIVER CIRRHOSIS; ARTICLE; CELL DAMAGE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; DISEASE SEVERITY; DNA BINDING; ELECTROPHORETIC MOBILITY; EXPLANT; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; POLYMERASE CHAIN REACTION; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; QUANTITATIVE DIAGNOSIS; WESTERN BLOTTING;

EID: 0037331245     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)63852-7     Document Type: Article

References (40)

1. Beg AA, Finco TS, Nantermet PV, Baldwin AS: Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of IκBα: a mechanism for NF-κB activation. Mol Cell Biol 1993, 13:3301-3310
2. Verma IM, Stevenson JK, Schwarz EM, Van Antwerp D, Miyamoto S: Rel/NFκB/IκB family: intimate tales of association and dissociation. Genes Dev 1995, 9:2723-2735
3. May MJ, Ghosh S: Signal transduction through NF-κB. Immunol Today 1998, 19:80-88
4. Tomasz K, Bugno M, Goldstein J, Travis J: Activation of signal transducer and activator of transcription-3 (STAT3) expression by interferon-γ and interleukin-6 in hepatoma cell. Biochem Biophys Res Commun 1995, 216:999-1005
5. Zhang D, Sun M, Samols D, Kushner I: STAT3 participates in transcriptional activation of the C-reactive protein gene by interleukin-6. J Biol Chem 1996, 271:9503-9509
6. Strain AJ, Diehl AM (Eds): Liver Growth and Repair. London, Chapman & Hall, 1998
7. Kamimura S, Tsukamoto H: Cytokine gene expression by Kupffer cells in experimental alcoholic liver disease. Hepatology 1995, 21:1304-1309
8. Iimuro Y, Gallucci RM, Luster MI, Kono H, Thurman RG: Antibodies to tumor necrosis factor alpha attenuate hepatic necrosis and inflammation caused by chronic exposure to ethanol in the rat. Hepatology 1997, 26:1530-1537
9. Yamada Y, Kirillova I, Peschon JJ, Fausto N: Initiation of liver growth by tumor necrosis factor: deficient liver regeneration in mice lacking type I tumor necrosis factor receptor. Proc Natl Acad Sci USA 1997, 94:1441-1446
10. Cressman DE, Greenbaum LE, DeAgelis RA, Ciliberto G, Furth EE, Poli V, Taub R: Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science 1996, 274:1379-1383
11. Lin HZ, Yang SQ, Zeldin G, Diehl AM: Chronic ethanol consumption induces the production of tumor necrosis factor-alpha and related cytokines in liver and adipose tissue. Alcohol Clin Exp Res 1998; 22:231S-237S
12. Nanji AA, Jokelainen K, Rahemtulla A, Miao L, Fogt F, Matsumoto H, Tahan SR, Su GL: Activation of nuclear factor kappa B and cytokine imbalance in experimental alcoholic liver disease in the rat. Hepatology 1999, 30:934-943
13. McClain CJ, Cohen DA: Increased tumor necrosis factor production by monocytes in alcoholic hepatitis. Hepatology 1989, 9:349-351
14. Bird GLA, Sheron N, Goka AKJ, Alexander GL, Williams RS: Increased plasma tumor necrosis factor in severe alcoholic hepatitis. Ann Intern Med 1990, 112:917-920
15. Felver ME, Mezey E, McGuire M, Mitchell MC, Herlong HF, Veech GA, Veech RL: Plasma tumor necrosis factor alpha predicts decreased long-term survival in severe alcoholic hepatitis. Alcohol Clin Exp Res 1990, 14:255-259
16. Khoruts A, Stahnke L, McClain CJ, Logan G, Allen JI: Circulating tumor necrosis factor, interleukin-1 and interleukin-6 concentrations in chronic alcoholic patients. Hepatology 1991, 13:267-276
17. Hill DB, Marsano L, Cohen D, Allen J, Shedlofsky S, McClain CJ: Increased plasma interleukin-6 concentrations in alcoholic hepatitis. J Lab Clin Med 1992, 119:547-552
18. Llorent L, Richaud-Patin Y, Alcocer-Castillejos N, Ruiz-Soto R, Mercado MA, Orozco H, Gambao-Dominguez A, Alcocer-Varela J: Cytokine gene expression in cirrhotic and non-cirrhotic human liver. J Hepatol 1996, 24:555-563
19. Tilg H, Diehl AM: Mechanisms of disease: cytokines in alcoholic and nonalcoholic steatohepatitis. N Engl J Med 2000, 343:1467-1476
20. Akriviadis E, Bolta R, Briggs W, Han S, Reynolds T, Shakil O: Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial. Gastroenterology 2000, 119:1637-1648
21. Tilg H: The role of cytokines in the pathophysiology of chronic liver diseases. Int J Clin Lab Res 1993, 23:179-185
22. Diehl AM: Cytokines and the molecular mechanisms of alcoholic liver disease. Alcohol Clin Exp Res 1999, 23:1419-1424
23. Greenbaum LE, Li W, Cressman DE, Peng Y, Ciliberto G, Poli V, Taub R: CAAT enhancer-binding protein β is required for normal hepatocyte proliferation in mice after partial hepatectomy. J Clin Invest 1998, 102:996-1007
24. Chirgwin JM, Przybla AE, MacDonald RJ, Rutter WJ: Isolation of biologically active ribonucleic acid from sources enriched in ribonucleases. Biochemistry 1979, 18:5294-5299
25. Suematsu T, Matsumura T, Sato N, Miyamoto T, Ooka T, Kamada T, Abe H: Lipid peroxidation in alcoholic liver disease in humans. Alcohol Clin Exp Res 1981, 5:427-430
26. Shaw S, Rubin KP, Lieber CS: Depressed hepatic glutathione and increased diene conjugates in alcoholic liver disease. Evidence of lipid peroxidation. Dig Dis Sci 1983, 28:585-589
27. Tai D, Tsai S, Chen Y, Chuang Y, Peng C, Sheen I, Yeh C, Chang KSS, Huang S, Kuo GC, Liaw Y: Activation of nuclear factor κB in hepatitis C virus infection: implications for pathogenesis and hepatocarcinogenesis. Hepatology 2000, 31:656-664
28. Schmid RM, Adler G: NF-κB/Rel/IκB: implications in gastrointestinal diseases. Gastroenterology 2000, 118:1208-1228
29. Heinrich PC, Behrmann I, Muller-Newen G, Schaper F, Graeve L: Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway. Biochem J 1998, 334:297-314
30. Ghosh S, May MJ, Kopp EB: NF-κB and rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol 1998, 16:225-260
31. Schindler C, Darnell JE: Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. Annu Rev Biochem 1995, 64:621-651
32. Chen J, Bao H, Sawyer S, Kunos G, Gao B: Effects of short and long term ethanol on the activation of signal transducer and activator transcription factor 3 in normal and regenerating liver. Biochem Biophys Res Commun 1997, 239:666-669
33. Chen J, Kunos G, Gao B: Ethanol rapidly inhibits IL-6-activated STAT3 and C/EBP mRNA expression in freshly isolated rat hepatocytes. FEBS Lett 1999, 457:162-168
34. Schindler C, Darnell JE: Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. Annu Rev Biochem 1995, 154:294-300
35. Degawa-Yamauchi M, Uotani S, Yamaguchi Y, Takahashi R, Abe T, Kuwahara H, Yamasaki H, Eguchi K: Ethanol inhibits leptin-induced STAT3 activation in Huh7 cells. FEBS Lett 2002, 525:116-120
36. Chung CD, Liao J, Liu B, Rao X, Jay P, Berta P, Shuai K: Specific inhibition of Stat3 signal transduction by PIAS3. Science 1997, 278:1803-1805
37. Ueki N, Seki N, Yano K, Saito T, Masuho Y, Muramatsu M: Isolation and chromosomal assignment of a human gene encoding protein inhibitor of activated STAT3 (PIAS3). J Hum Genet 1999, 44:193-196
38. Gisselbrecht S: The CIS/SOCS proteins: a family of cytokine-inducible regulators of signaling. Eur Cytokine Netw 1999, 10:463-470
39. Yasukawa H, Sasaki A, Yoshimura A: Negative regulation of cytokine signaling pathways. Annu Rev Immunol 2000, 18:143-164
40. Luedde T, Wuestefeld T, Trautwein C: A new player in the team: SOCS-3 socks it to cytokine signaling in the regenerating liver. Hepatology 2001, 34:1254-1256